A detailed history of First Horizon Advisors, Inc. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 370 shares of XENE stock, worth $15,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares
370
Previous 370 -0.0%
Holding current value
$15,284
Previous $14,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$42.66 - $50.04 $8,532 - $10,008
-200 Reduced 35.09%
370 $15,000
Q2 2023

Aug 03, 2023

BUY
$34.84 - $43.54 $12,890 - $16,109
370 Added 185.0%
570 $21,000
Q1 2023

May 15, 2023

BUY
$33.46 - $40.35 $6,692 - $8,070
200 New
200 $7,000

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.57B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.